...
【24h】

Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients

机译:错配修复表型不足是老年大肠癌的预后因素

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: About 15% of colorectal adenocarcinomas have a deficient DNA mismatch repair phenotype. The frequency of deficient DNA mismatch repair tumours increases with age due to the hypermethylation of hMLH1 promoter. The study aimed to determine the prognostic value of deficient DNA mismatch repair phenotype in elderly patients. Design: Mismatch repair phenotype was retrospectively determined by molecular analysis in consecutive resected colorectal adenocarcinoma specimens from patients over 75 years of age from 4 Oncology centres. Results: 231 patients (median age: 81, range: 75-100) were enrolled from 2005 to 2008. Mean prevalence of deficient DNA mismatch repair phenotype was 22.5%, and 36% for patients over 85 years. Deficient DNA mismatch repair status was significantly associated with older age, female sex, proximal colon primary and high grade tumour. For stage II tumours no deficient DNA mismatch repair tumours had a recurrence at end of follow-up compared to 17% for tumours with proficient phenotype. The proficient phenotype status was significantly associated with worse age-adjusted overall survival [HR 2.60; 95% CI 1.05-6.44; p=0.039]. For stage III tumours a trend for less recurrence was observed for deficient DNA mismatch repair phenotype (16%) compared to proficient phenotype (36%). Conclusion: deficient DNA mismatch repair phenotype is a prognostic factor in stage II colorectal tumour in elderly patients. Our results suggest that mismatch repair phenotype should be taken in consideration for adjuvant chemotherapy decision in elderly patients. ? 2012 Editrice Gastroenterologica Italiana S.r.l..
机译:目的:约15%的大肠腺癌具有DNA错配修复表型不足。由于hMLH1启动子的高度甲基化,缺陷的DNA错配修复肿瘤的频率随年龄增加。该研究旨在确定DNA错配修复表型不足对老年患者的预后价值。设计:通过分子分析回顾性分析了来自四个肿瘤学中心的75岁以上患者的连续切除的结直肠腺癌标本中的错配修复表型。结果:2005年至2008年共纳入231例患者(中位年龄:81岁,范围:75-100岁)。缺陷DNA错配修复表型的平均患病率为22.5%,而85岁以上患者的平均患病率为36%。 DNA错配修复状态不足与年龄,女性,近端结肠原发癌和高级别肿瘤显着相关。对于II期肿瘤,随访结束时无缺陷的DNA错配修复肿瘤复发,而具有良好表型的肿瘤为17%。熟练的表型状态与较差的年龄调整后的总生存率显着相关[HR 2.60; 95%CI 1.05-6.44; p = 0.039]。对于III期肿瘤,与熟练的表型(36%)相比,缺陷的DNA错配修复表型(16%)观察到复发的趋势。结论:缺陷的DNA错配修复表型是老年患者II期大肠癌的预后因素。我们的结果表明,对于老年患者,辅助化疗的决策应考虑错配修复表型。 ? 2012年义大利肠胃病学杂志(Editrice Gastroenterologica Italiana S.r.l ..

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号